12/27 Meta
, A., Preprint (Preprint) (meta analysis)
Meta-analysis of clinical trials of ivermectin to treat COVID-19 infection
Meta-analysis of clinical trials of ivermectin to treat COVID-19 infection
WHO-funded meta analysis showing ivermectin treatment mortality relative risk RR 0.17 [0.08-0.35] for RCTs and RR 0.28 [0.13-0.62] for RCTs and observational studies, and confirming a dose-response effect.
Hill et al., 12/27/2020, preprint, 1 author.
